Castle Biosciences CEO Derek J. Maetzold disposes of 550 common shares worth $12,606‬‬

Reuters2026/07/16 20:16

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Castle Biosciences CEO Derek J. Maetzold exercised stock options for 550 shares at USD 2.39 on July 14, 2026.
Maetzold sold 550 shares at a weighted-average USD 22.92, cutting his direct stake to 21,479 shares.
Trust-held positions also fell via sales at USD 22.92, including 1,357 shares from The Maetzold Descendants 2020 Trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-048461), on July 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Castle Biosciences CEO Derek J. Maetzold disposes of 550 common shares worth $12,606‬‬

You may also like

Crypto prices